CONMED Co. (NYSE:CNMD – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target […]
CONMED Co. (NYSE:CNMD – Get Free Report) declared a quarterly dividend on Monday, February 26th, Wall Street Journal reports. Stockholders of record on Friday, March 15th will be paid a dividend of 0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.94%. The […]
CONMED Co (NYSE:CNMD) Given Consensus Recommendation of Moderate Buy by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
CONMED Co (NYSE:CNMD) Receives Average Rating of Moderate Buy from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Research Analysts’ price target changes for Thursday, February 1st: Align Technology (NASDAQ:ALGN) had its target price boosted by Piper Sandler from $290.00 to $335.00. The firm currently has an overweight rating on the stock. Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its price target trimmed by Piper Sandler from $12.00 to $5.00. They currently have an overweight […]